Intellia Therapeutics's total assets for Q1 2025 were $986.16M, a decrease of -17.20% from the previous quarter. DE:38I total liabilities were $206.24M for the fiscal quarter, a -35.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.